254 related articles for article (PubMed ID: 15754653)
21. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC
Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
[TBL] [Abstract][Full Text] [Related]
22. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
[TBL] [Abstract][Full Text] [Related]
23. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
24. [Resistance to antibiotics of Proteus strains from various sources].
Korneva EP; Baĭramova AS; Iakh'eva SA; Slutskiĭ VI; Danevich MV
Antibiotiki; 1984 Apr; 29(4):263-71. PubMed ID: 6378079
[TBL] [Abstract][Full Text] [Related]
25. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
Yayan J; Ghebremedhin B; Rasche K
BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
[TBL] [Abstract][Full Text] [Related]
26. [Interrelationship between Proteus mirabilis proticin type and its resistance to antibiotics].
Nieradko J
Przegl Epidemiol; 1977; 31(1):23-7. PubMed ID: 329359
[No Abstract] [Full Text] [Related]
27. Plasmid-mediated, inducible AmpC beta-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis.
Yong D; Lim Y; Song W; Choi YS; Park DY; Lee H; Yum JH; Lee K; Kim JM; Chong Y
Diagn Microbiol Infect Dis; 2005 Sep; 53(1):65-70. PubMed ID: 15936167
[TBL] [Abstract][Full Text] [Related]
28. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
Kwiecińska-Piróg J; Bogiel T; Gospodarek E
J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
[TBL] [Abstract][Full Text] [Related]
29. [Antibiotic sensitivity of the H- and O-forms of bacteria in the genus Proteus].
Nesterova GN; Leont'eva AN; Savinova VM
Antibiotiki; 1978 Sep; 23(9):802-4. PubMed ID: 358911
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of antimicrobial agents against Proteus species from clinical specimens.
Na'was TE; Mawajdeh S; Dababneh A; al-Omari A
Br J Biomed Sci; 1994 Jun; 51(2):95-9. PubMed ID: 8049615
[TBL] [Abstract][Full Text] [Related]
31. [Dynamics of drug resistance in Proteus mirabilis cultures 1970-1985].
Shvidenko IG
Antibiot Khimioter; 1988 Apr; 33(4):294-7. PubMed ID: 3291802
[TBL] [Abstract][Full Text] [Related]
32. [Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Gospodarek E; Gierlotka K; Deptuła A; Michalska A
Med Dosw Mikrobiol; 2007; 59(3):231-40. PubMed ID: 18078118
[TBL] [Abstract][Full Text] [Related]
33. [ESBL-positive and ESBL-negative Klebsiella pneumoniae and Klebsiella oxytoca strains--occurrence in clinical specimens and susceptibility to selected antibiotics].
Sekowska A; Wróblewska J; Gospodarek E
Med Dosw Mikrobiol; 2008; 60(1):39-44. PubMed ID: 18634342
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms.
Lautenbach E; Strom BL; Nachamkin I; Bilker WB; Marr AM; Larosa LA; Fishman NO
Clin Infect Dis; 2004 Mar; 38(5):655-62. PubMed ID: 14986249
[TBL] [Abstract][Full Text] [Related]
35. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad.
Orrett FA
Saudi Med J; 2005 Nov; 26(11):1766-70. PubMed ID: 16311663
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
37. Transmissible drug resistance in Proteus mirabilis.
Rao RS; Sundaraj T; Subramanian S
Indian J Pathol Microbiol; 1984 Jan; 27(1):37-42. PubMed ID: 6392091
[No Abstract] [Full Text] [Related]
38. Two nosocomial strains of Stenotrophomonas maltophilia transferring antibiotic resistance to Proteus mirabilis P-38 recipient strain.
Blahová J; Králiková K; Krcméry V; Chmelarová E; Torsová V
J Chemother; 1998 Feb; 10(1):22-4. PubMed ID: 9531071
[TBL] [Abstract][Full Text] [Related]
39. Studies of antibiotic resistance of rough and smooth Proteus mirabilis strains and influence of polymyxin E on their lipopolysaccharide composition.
Kaca W; Ujazda E
Acta Microbiol Pol; 1996; 45(2):161-8. PubMed ID: 8997693
[TBL] [Abstract][Full Text] [Related]
40. First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated bla
Kanzari L; Ferjani S; Saidani M; Hamzaoui Z; Jendoubi A; Harbaoui S; Ferjani A; Rehaiem A; Boutiba Ben Boubaker I; Slim A
Int J Antimicrob Agents; 2018 Dec; 52(6):906-909. PubMed ID: 29958975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
